Duan J, Wu L, Yang K, Zhao J, et al. Safety, tolerability, pharmacokinetics, and preliminary efficacy of YK-029A in treatment-naive patients with advanced non-small cell lung cancer harboring EGFR exon 20 insertion mutations: A phase I trial. J Thorac Oncol 2023 Sep 28:S1556-0864(23)02259.
PMID: 37776953